Abstract Details

Title Aggressive Medical Care at the End of Life (EOL) in Glioblastoma (GBM): The 5-year Memorial Sloan-Kettering Cancer Center (MSKCC) Experience

Topic Neuro-oncology

Presentation(s) (-)

Poster/Presentation
Number 273

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Alexis M. Dallara-Marsh, MD PRESENTER	No disclosure on file
Alan C. Carver, MD (Memorial Sloan Kettering Cancer Center)	No disclosure on file
Eli Diamond, MD (Memorial Sloan-Kettering Cancer Center)	Dr. Diamond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Day One Biopharmaceuticals. Dr. Diamond has received research support from Applebaum Foundation. Dr. Diamond has received research support from Frame Family Fund. Dr. Diamond has received research support from Joy Family West Foundation.
	No disclosure on file

��ɫ��